Next Article in Journal
Formation of Microporous Poly Acrylonitrile-Co-Methyl Acrylate Membrane via Thermally Induced Phase Separation for Immiscible Oil/Water Separation
Previous Article in Journal
Chemical Investigation on the Volatile Part of the CO2 Supercritical Fluid Extract of Infected Aquilaria sinensis (Chinese Agarwood)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 10
10.3390/molecules29102299
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Bodipy-Tagged Galactoconjugates and Evaluation of Their Antibacterial Properties

by
Chiara Maria Antonietta Gangemi
1,
Maura Monforte
1,
Antonino Arrigo
1,
Paola Maria Bonaccorsi
1,
Sabrina Conoci
1,2,3,
Antonella Iaconis
1,
Fausto Puntoriero
1,
Domenico Franco
1,* and
Anna Barattucci
1,*
1
Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, Università degli Studi di Messina, V.le F. Stagno D’Alcontres 31, 98166 Messina, Italy
2
Dipartimento di Chimica “Giacomo Ciamician”, Università di Bologna, Via Francesco Selmi, 2, 40126 Bologna, Italy
3
LAB Sense Beyond Nano—URT Department of Sciences Physics and Technologies of Matter (DSFTM) CNR, 98166 Messina, Italy
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(10), 2299; https://doi.org/10.3390/molecules29102299
Submission received: 12 April 2024 / Revised: 30 April 2024 / Accepted: 9 May 2024 / Published: 14 May 2024
(This article belongs to the Special Issue Synthesis and Applications of Fluorescent Probes)
Browse Figures
Versions Notes

Abstract

:
As a development of our research on biocompatible glycoconjugate probes and specifically multi-chromophoric systems, herein, we report the synthesis and early bactericidal tests of two luminescent glycoconjugates whose basic structure is characterized by two boron dipyrromethene difluoride (BODIPY) moieties and three galactoside rings mounted on an oligophenylene ethynylene (OPE) skeleton. BODIPY fluorophores have found widespread application in many branches of biology in the last few decades. In particular, molecular platforms showing two different BODIPY groups have unique photophysical behavior useful in fluorescence imaging. Construction of the complex architecture of the new probes is accomplished through a convergent route that exploits a series of copper-free Heck–Cassar–Sonogashira cross-couplings. The great emergency due to the proliferation of bacterial infections, in conjunction with growing antibiotic resistance, requires the production of new multifunctional drugs and efficient methods for their targeted delivery to control bacteria-associated diseases. Preliminary studies of the glycoconjugate properties as antibacterial agents against representatives of Gram-negative (P. aeruginosa) and Gram-positive (S. aureus) pathogens, which are associated with chronic infections, indicated significant bactericidal activity ascribable to their structural features.

Graphical Abstract

1. Introduction

Luminescent glycoconjugates provide significant tools for the exploitation of biological systems. The most significant applications in the biomedical field of such molecules are (1) imaging [1], where they act as targeting probes, with the luminescent part guaranteeing great photo illumination and the sugar moiety as structural recognition element of the probe, and (2) sensing [2], where the luminescent molecule must be able to undergo changes in its lighting to act as a sensing element, with the sugar moiety improving the selectivity and solubility in aqueous media. A further development can be the design and development of fluorescent glycoconjugates for theranostic applications, in which the probe is used to image a specific cell or pathogen and, after activation, kill the target in a therapeutic approach [3].
Carbohydrates possess stereochemical and structural diversity provided by nature and synthetic chemistry [4] that constitute their imprinting in recognition phenomena and the pathological events of biological and physiological processes [5]. Mono- and oligosaccharides decorate proteins of the cellular membranes, giving access to a great variety of glycoproteins that represent a versatile molecular signal system in cells, such as in the endocytosis process. Carbohydrates’ natural widespread nature and capability of forming different kinds of chemical bonds with stereochemical differentiation expanded their use in the synthesis of luminescent probes and particularly fluorescent organic small molecule probes involved in biological investigations [6]. The rational design and feasibility of the synthesis of such probes, as well as their stable luminescence and high signal-to-noise ratio, make them an advantageous choice for in vivo imaging [7]. Additionally, carbohydrate conjugation helps to achieve low cytotoxicity and good cell permeability and targeting properties [8].
Boron Dipyrromethene difluoride (BODIPY) derivatives are usually chosen as dyes for many applications in the biological and medicinal fields [9], such as molecular imaging and luminescence-guided surgery, due to their high absorption coefficients in the visible region, good luminescence properties, high photostability, weak dependence on environmental conditions, small size, and finally their chemical versatility for core modification with target molecules [10]. For practical applications, the use of at least two different BODIPY derivatives on a molecular platform [11], with close proximity and significant spectral overlap, is encouraged by the high fluorescence quantum yields and large Stokes shifts of such bichromophoric species, with a high difference between the excitation and the emission energy, which allow the suppression of photon scattering and diminish tissue autofluorescence in fluorescence imaging [12].
In continuing our research on biocompatible glycoconjugates [13] and particularly multichromophoric systems in which differently substituted BODIPY moieties, chosen to function as artificial antenna systems with extremely efficient and fast coulombic energy transfer, were linked to more than one sugar skeleton, in this paper, we describe the synthetic procedure of luminescent galactoconjugates GalTEBB-1 and GalTEBB-2 (Figure 1), where two BODIPY moieties and three galactoside rings are mounted onto an oligophenylenethynylene (OPE) skeletal support [14].
Apart from the bichromophoric nature of the two BODIPY derivatives, which is assessed thoroughly in this paper by through photophysical characterizations, the luminescent glycoconjugates GalTEBB-1 and GalTEBB-2 were conceived as derivatives targeting bacterial infections [15], with the luminescent portion constituted by the OPE and the two BODIPY residues, known in the literature as antibacterial materials [16], as well as the galactosyl moieties chosen for the capacity of several galactose-binding lectins [17,18] to modulate antibiotic activity against the Staphylococcus (S.) aureus and Escherichia coli bacterial strains [15]. New drugs and efficient strategies are required to control bacteria-associated infections due to the emergence and rapid dissemination of antibiotic resistance. To address this, various antimicrobial drugs [19] (e.g., antibacterial peptides and amphiphiles) and antibacterial materials [20] (e.g., nanoparticles [21], hydrogels, engineered surfaces [22], and surface coatings [23]) have been developed. In addition, the presence of two tetralkylammonium functionalities within the structural skeleton of one of the two BODIPY derivatives strengthened the possibility of GalTEBB-2 acting as an antimicrobial agent against Staphylococcus strains, including methicillin-resistant S. aureus (MRSA) [24], or eradicating bacterial biofilms [25] without losing the luminescence properties of the BODIPY scaffolds.
In this paper, we report preliminary studies on the properties of GalTEBB-1 and GalTEBB-2 as antibacterial agents against Pseudomonas aeruginosa and Staphylococcus aureus, Gram- negative and Gram- positive representative strains, respectively [26], and common causes of nosocomial, difficult-to-eradicate infections.

2. Results and Discussion

2.1. Synthesis

With the aim to build-up the basic OPE skeleton of galactoconjugate chromophores GalTEBB-1 and GalTEBB-2, two convergent routes were realized, involving the syntheses of triglycosidic moiety 6 and bichromophoric species 10. The presence of terminal alkyne and iodoarene functionalities within all the substructures allowed the use of the copper-free Heck–Cassar–Sonogashira [26] reaction as the principal means for their connection, while paying particular attention to the molar ratios to obtain good yields and minimize the formation of side-products. We reproposed [27] the use of a multifunctionalized platform such as 1,3,5-triethynylbenzene that could guarantee a radial OPE system [28].
The synthetic procedure for digalactoside 4 [29] is reported in Scheme 1. Iodination of 1,4-dimethoxybenzene led to compound 1, and subsequent treatment with BBr3 led to 2,5-diiodohydroquinone (compound 2) [30]. The reaction of compound 2 with ClSiMe3, in the presence of HDMS, gave compound 3, the BF3Et2O treatment of which [31], in the presence of β-D-galactopyranoside pentaacetate, afforded compound 4, which was simply purified by crystallization from methanol. The syntheses of compound 5 [32], BDP-R 7 [33], and BDP-G 8 [34] were already reported.
Compounds 4 and 5 were cross-coupled in the presence of Pd(PPh3)4, as a catalyst, at a 2:1 stoichiometric ratio in such a way as to make the functionalization take place over only one reactive site of the ring. The reaction was complete in 7 h and, compound 6 was obtained at a 35% yield after purification (Scheme 2A). The applied conditions were the best we could experiment with to avoid side-products, even if a modest yield was achieved for compound 6, which is attributable to the tetra-functionalization of the aromatic ring and the long but necessary reaction time. The excess of unreacted compound 4 was recovered and available to be reacted with again.
The parallel route for synthesis of bichromophoric species 10 is reported in Scheme 2B. A large excess of 1,3,5-triethynylbenzene was reacted with BDP-R 7 in copper-free Sonogashira conditions for the obtainment of compound 9. The use of a 1:8 stoichiometric ratio between the reactants gave the best results in terms of yield (80%). The excess of 1,3,5-triethynylbenzene was recovered as the first eluate of the column and quantitively recrystallized from hexane. The second chromophore unit BDP-G 8 was inserted into the OPE skeleton, involving compound 9 in a further Pd(0) mediated cross-coupling, which this time was in the presence of a molar defect of BDP-G 8. The reaction conditions were optimized (molar ratio for compound 9 and BDP-G 8 of 3:1) to promote the formation of compound 10 as the main product, a dark green solid, at a 76% yield. Compound 10 contained one last ethynyl arm to be easily connected with galactoconjugate (compound 6). Therefore, once the syntheses of the precursors were completed, the next step was their assembly (Scheme 2C). An easy and straightforward copper-free cross-coupling between compounds 6 and 10 led to GalTEBB-1 at a 47% yield after purification as a dark green solid. The conversion of GalTEBB-1 to bis-tetraalkylammonium GalTEBB-2 was reached using a large excess of iodomethane in DCM at reflux for three days in a sealed tube in order to keep the excess of the toxic volatile reactant and the reaction volume unchanged during the full reaction time. The reaction was quantitative, and deep blue crystals of GalTEEB-2 were recovered by evaporation of the solvent and iodomethane in safe conditions. All the new products were fully characterized by mono- and bidimensional NMR spectroscopy and ESI-mass spectrometry to obtain their proper attributes (ESI, from Figures S4–S6).

2.2. Photophysical Characterizations

In Table 1, the photophysical characterizations of the two luminescent glycoconjugates are reported.
The absorption spectra of GalTEBB-1 and GalTEBB-2 in CH3CN are shown in Figure 2.
As can be seen, both spectra were characterized by intense absorption bands in the UV and visible regions of the electromagnetic spectrum.
In the UV region, it is possible to observe a set of bands attributable to π → π* transitions, leading to a population of S2 singlet states of BODIPY moieties layered over with the π → π* transitions centered on the radial OPE core. In the visible region, on the other hand, two different bands are distinguishable. The first one, centered at 500 nm, was due to π→ π* transitions involving the BDP-R moiety, whereas the contribution at lower energy (600 nm) is ascribable to the population of the S1 states centred on the BPD-G fragment in the case of GalTEBB-2 and to π → π* transitions with a charge transfer (CT) contribution involving the BPD-G (700 nm) fragment for GalTEBB-1.
Indeed, it is important to point out that the presence of a free electron pair on the peripheral fragment of the BDP-G chromophore in GalTEBB-1 conferred a charge transfer (CT) character to lowest-lying band, which was lacking in GalTEBB-2 due to the quaternarization of the amine group [35]. This difference between the two species was also found in the luminescence behavior. Both multicromophoric systems were emissive, as shown in Figure 3.
Independent of the excitation wavelength, GalTEBB-1 exhibited radiative deactivation from the lower-lying excited state localized on the BDP-G fragment.
The emission spectrum was large and structureless, confirming the CT nature of the excited state. There was no evidence of residual emission from the OPE core or from the BDP-R fragment, known to be centered at 510 nm [36], suggesting that an intramolecular energy transfer process was active in this system (see Scheme 3). To confirm this behavior, excitation spectra readings at the maximum emissions (λmax = 790 nm, f = 0.2, and t = 2.6 ns) were registered (see Figures S3 and S4 in the ESI), from which it is possible to state that BDP-R absorption also contributed efficiently to the population of the emissive state in GalTEBB-1.
A similar discussion can take place for GalTEBB-2. The emission spectrum was essentially localized at a higher energy value (lmax = 625 nm, f = 0.7, and t = 5.6 ns) and was much narrower and more structured with respect to the one exhibited by GalTEBB-1, indicating that it came from a pure p* state. Interestingly, the quantum yields for these molecules became high when amine groups were protonated or quaternarized, because in these conditions, the intramolecular charge transfer (ICT) process is not favored in an excited state [37]. Also, in this case, regardless of the excitation wavelength, the luminescence was observed exclusively from the lower-energy excited state localized on the BDP-B fragment. The excitation spectrum (see Figure S4 in ESI) confirmed a photoinduced energy transfer process from the BDP-R moiety (Scheme 3).

2.3. Biological Results

The bactericidal activity of GalTEBB-1 and GalTEBB-2 was established through biological assays against P. aeruginosa and S. aureus in the range of 15.6–250 µg/mL. Citotoxicity was also tested (Figure S5 in ESI). The lipophilic compounds were dissolved in DMSO, the antimicrobial properties of which are well known [38]. In order to avoid reporting false positive antimicrobial effects [39], we decided to also evaluate DMSO alone in the range of 0.78–12.5% (w/v), representing the proportional percentages of the organic solvent in the solutions of GalTEBB-1 and GalTEBB-2, as shown in Table S1 (ESI). Thus, the bactericidal activity of GalTEBB-1 and GalTEBB-2 was confirmed by comparison with the data from the DMSO alone.
The results are summarized in Figure 4.
The DMSO showed a stronger antibacterial action against P. aeruginosa than S. aureus. Regarding P. aeruginosa, the MIC of the DMSO was established at 6.25% (w/v), and an almost total reduction (over 99% compared with the control condition without compounds (CTR+)) of the bacterial load was observed. On the other hand, when this broth dilution was sub-cultured onto DMSO-free agar plates, the presence of viable bacteria was still observed. Therefore, the MBC was set at 3.12% (w/v). Regarding S. aureus, significant bacteria viability (14% compared with the control condition without compounds (CTR+)) was still observed at the highest concentration (12.5%, w/v) of DMSO. For this bacterial strain, both the MIC and MBC were found to be 25%, which are concentrations that were not used in the present work.
Based on the above, bactericidal activity was asserted on GalTEBB-1 and GalTEBB-2. The data obtained after overnight (18 h) incubation (for experiments conducted after light illumination, see Figure S6 in ESI) show that both compounds exhibited significant antibacterial activity with respect to the control (bacterial culture without compounds (CTR+)), albeit to varying degrees in relation to belonging to the Gram-negative or Gram-positive group. Regarding P. aeruginosa, both the MIC and MBC were identified to be 125 µg/mL for both galactoconjugates. At this value, the proportional percentage of DMSO, namely 6.25% (w/v), was found for the MIC but not the MBC. These findings indicate that at these concentrations, total killing of the bacteria was obtained by the presence of the galactoconjugates. Furthermore, the optical density values at 540 nm (OD540) at each concentrations tested indicated a higher antibacterial effect of the galactoconjugates on bacterial growth compared with DMSO. The data were confirmed by Tukey’s multiple comparisons, for which a significant difference between the two galactoconjugates and DMSO alone was always observed, except for GalTEBB-2 at a concentration of 15.6 µg/mL (Table S2, ESI). Concerning S. aureus, both the MIC and MBC were identified to be 250 µg/mL. In this case, the proportional percentage of DMSO, namely 6.25% (w/v), induced a reduction of 86% of the bacterial load, and the antibacterial activity was mainly due to GalTEBB-1 and GalTEBB-2. In analogy with the results for P. aeruginosa, Tukey’s multiple comparisons indicated a significant difference between the two galactoconjugates and DMSO alone at the other concentrations tested (Table S3, ESI).
The MIC and MBC of GalTEBB-1 and GalTEBB-2 related to DMSO are summarized in Table 2.
The data indicate that both galactoconjugates had significant bactericidal activity, mostly against the Gram-negative strain. These findings could be partially due to the use of DMSO as a solvent. In fact, the action of the organic solvent on the lipopolysaccharide of the outer membrane in the Gram-negative strain could favor the uptake of the galactoconjugates. Conversely, the Gram-positive strain appeared to be less affected by the organic solvent due to its cell wall, consisting almost exclusively of peptidoglycan. Regarding the differences between the antibacterial activities of the two galactoconjugates, the data suggest that the cationic structure of GalTEBB-2 did not boost antibacterial efficiency against the bacteria strains under study [40], as we wished.

3. Conclusions

In conclusion, we described a synthetic pathway, based on the copper-free Heck–Cassar–Sonogashira reaction, for the obtainment of galactoconjugates with an oligophenylenethynylene platform not lit by the presence of two BODIPY moieties. The use of the Pd-catalyzed reaction allowed the development of a convergent synthetic approach to achieve the desired compounds with satisfactory overall yields. GalTEBB-1 and GalTEBB-2 can be pictured as glycosyl bichromophoric probes that emit light in the red region of the visible electromagnetic spectrum, exhibiting a quite large Stokes shift thanks to a rather efficient intramolecular photoinduced energy transfer process. Therefore, these new species could be used in the field of high-resolution light microscopy and found by engaging in bioimaging as well.
Aside from that, GalTEBB-1 and GalTEBB-2 showed good antibacterial properties that are ascribable to their structural features, and for these reasons, studies on their action against antibacterial biofilms are ongoing.

4. Experimental Compounds

Compound 6: First, 2-propynil-O-β-galactopyranoside-2,3,4,6-tetraacetate (5) (0.43 g and 1.11 mmol, 1 equivalent), 1,4-bis-(2,3,4,6-tetra-O-acetyl-D-β-galactopyranosil)-2,5-diiodobenzene (4) (2.25 g and 2.20 mmol, 2 equivalent), Pd(PPh3)4 (26.48 mg and 0.023 mmol, 0.13 equivalent), and Et3N (10.6 mL) were dissolved into dry DMF (10.6 mL). The reaction mixture was maintained under stirring and an inert atmosphere until the disappearance of compound 5 (7 h) by TLC (hexane/ethyl acetate 55:45). The solvent was removed under reduced pressure, and the crude product was purified by a chromatographic column in silica gel, using as eluant hexane/ethyl acetate at a 70:30 ratio. Compound 6 was obtained as a low-melting solid (0.49 g, 0.39 mmol) (Rf = 0.32, hexane/ethyl acetate 55:45) with a yield of 35%.
Compound 9: Compound BDP-R 7 (0.4 g, 0.89 mmol, 1 equivalent), 1,3,5-triethynylbenzene (1.07 g, 7.12 mmol, 8 equivalent), Pd(PPh3)4 (0.013 g, 0.11 mmol, 0.13 equivalent), and dry Et3N (12 mL) were dissolved in dry DMF (12 mL). The reaction mixture was maintained under stirring at room temperature and an inert atmosphere for 1 h [41]. The solvent was removed under reduced pressure, and the crude product was purified by column chromatography in silica gel using hexane/dichloromethane (75:25) → DCM 100% as an eluant, obtaining 0.34 g of the desired compound 9 as brilliant red powder (Rf = 0.4 hexane/ethyl acetate (90:10)), with MP > 300 °C and a yield of 80%.
Compound 10: The compound BDP-G 8 (0.15 g, 0.21 mmol, 1 equivalent), compound 9 (0.30 g, 0.63 mmol, 3 equivalent) and Pd(PPh3)4 (0.032 g, 0.028 mmol, 0.13 equivalent) and dry Et3N (11.5 mL) were dissolved in dry DMF (11.5 mL) The reaction mixture was maintained under stirring at 60 °C and an inert atmosphere for 45 min. The solvent was removed under reduced pressure, and the crude product was purified by column chromatography in silica gel using hexane 100% → ethyl acetate 100% as an eluant, obtaining 0.17 g of the desired compound 10 (0.16 mmol) as dark green powder (Rf = 0.2, hexane/ethyl acetate 75:25), with MP > 300 °C and a yield of 76%.
GalTEBB-1: Compound 10 (0.127 g, 0.12 mmol, 1 equivalent), compound 6 (0.15 g, 0.12 mmol, 1 equivalent), and Pd(PPh3)4 (0.018 g, 0.015 mmol, 0.13 equivalent), and dry Et3N (1.4 mL) were dissolved in dry DMF (1.4 mL). The reaction mixture was maintained under stirring at 65 °C and an inert atmosphere for 4 h. The solvent was removed under reduced pressure, and the crude product was purified by column chromatography in silica gel using dichloromethane/ethyl acetate (92:8) → DCM/ethyl acetate (85:15), obtaining 0.124 g of GalTEBB-1 (0.056 mmol) as dark green powder (Rf = 0.2, dichloromethane/ethyl acetate (80:20)), with MP = 225–227 °C and a yield of 47%.
GalTEBB-2: Iodomethane (1.4 mL, 22.5 mmol, 500 equivalent) and GalTEBB-1 (0.10 g, 0.045 mmol, and 1 equivalent) were dissolved in DCM (3 mL). The reaction mixture was maintained under stirring at room temperature for 3 days. The reaction was monitored by TLC (acetonitrile/toluene (70:30)) until the disappearance of GalTEBB-1. GalTEBB-2 was obtained (0.11 g 0.044 mmol), after evaporation as dark blue powder in an almost quantitative yield (Al2O3, Rf = 0.34, acetonitrile/toluene (70:30)) with MP ˃ 300 °C.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29102299/s1, Figure S1: Excitation spectrum of GalTEBB-1 in CH3CN solution registered @790 nm; Figure S2: Excitation spectrum of GalTEBB-2 in CH3CN solution registered @690 nm; Figure S3: UV-Vis Absorption spectra of compound GalTEBB-1 and GalTEBB-2 in CH3CN; Figure S4: Emission spectra of compound GalTEBB-1 and GalTEBB-2 in CH3CN λex 450 nm; Figure S5: Optical microscope images of cell line hFOB 1.19 in normal conditions (A) and exposed to GalTEBB-1 (B) and 2 (C) at a final concentration of 62.5 µg/mL for 24 h; Figure S6: Antibacterial activity under a white-light source (26000 lux, fluence rate 3.81 mW/cm2) for 1 h (totalling 13.7 J/cm2 fluence) of DMSO (orange), GalTEBB-1 (green) and GalTEBB-2 (blue) against P. aeruginosa and S. aureus; Figure S7: 1H-NMR compound 6 in CDCl3; Figure S8: 13C-NMR compound 6 in CDCl3; Figure S9: 1H-NMR compound 9 in CDCl3; Figure S10: 13C-NMR compound 9 in CDCl3; Figure S11: 1H-NMR compound 10 in CDCl3; Figure S12: 13C-NMR compound 10 in CDCl3; Figure S13: 1H-NMR compound GalTEBB-1 in CDCl3; Figure S14: 13C-NMR compound GalTEBB-1 in CDCl3; Figure S15: 1H-NMR compound GalTEBB-2 in acetone-d6; Figure S16: 13C-NMR compound GalTEBB-2 in acetone-d6; Table S1: Correlation between of DMSO and bodipy-tagged galactoconjugates; Table S2: Bactericidal activity of DMSO, GalTEBB-1 and GalTEBB-2 against P. aeruginosa at different concentrations; Table S3: Bactericidal activity of DMSO, GalTEBB-1 and GalTEBB-2 against S. aureus at different concentrations. Refs. [32,42,43,44,45,46] are cited in Supplementary Materials.

Author Contributions

Conceptualization, A.B. and D.F.; methodology, C.M.A.G. and A.I.; formal analysis, A.A.; investigation, F.P. and M.M.; data curation, S.C.; writing—original draft preparation, P.M.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

This publication was created with the co-financing of the European Union-FSE-REACT-EU, the PON on Research and Innovation 2014–2020 (DM.1062/2021 and PNRR-M4C2), and the project “SiciliAn MicronanOTecH Research And Innovation Center-SAMOTHRACE” (ECS_00000022). The authors thank the University of Messina for their financial support (FFABR). The authors also thank Valentina Greco from the University of Catania (Italy) for the ESI mass analyses.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kim, Y.; Li, H.; Choi, J.; Boo, J.; Jo, H.; Hyun, J.Y.; Shin, I. Glycosidase-Targeting Small Molecules for Biological and Therapeutic Applications. Chem. Soc. Rev. 2023, 52, 7036–7070. [Google Scholar] [CrossRef] [PubMed]
  2. Kaltner, H.; Gabius, H.-J. Sensing Glycans as Biochemical Messages by Tissue Lectins: The Sugar Code at Work in Vascular Biology. Thromb. Haemost. 2019, 119, 517–533. [Google Scholar] [CrossRef]
  3. Thomas, B.; Yan, K.-C.; Hu, X.-L.; Donnier-Maréchal, M.; Chen, G.-R.; He, X.-P.; Vidal, S. Fluorescent Glycoconjugates and Their Applications. Chem. Soc. Rev. 2020, 49, 593–641. [Google Scholar] [CrossRef]
  4. Temperini, A.; Barattucci, A.; Bonaccorsi, P.M.; Rosati, O.; Minuti, L. Stereoselective Synthesis of Substituted Tetrahydropyrans and Isochromans by Cyclization of Phenylseleno Alcohols. J. Org. Chem. 2015, 80, 8102–8112. [Google Scholar] [CrossRef]
  5. Li, X.; Lv, P.; Du, Y.; Chen, X.; Liu, C. Emerging Roles of O-Glycosylation in Regulating Protein Aggregation, Phase Separation, and Functions. Curr. Opin. Chem. Biol. 2023, 75, 102314. [Google Scholar] [CrossRef]
  6. Arsić, A.; Hagemann, C.; Stajković, N.; Schubert, T.; Nikić-Spiegel, I. Minimal Genetically Encoded Tags for Fluorescent Protein Labeling in Living Neurons. Nat. Commun. 2022, 13, 314. [Google Scholar] [CrossRef]
  7. Kong, Y.; Jiang, Q.; Zhang, F.; Yang, Y. Small Molecular Fluorescent Probes: Application Progress of Specific Bacteria Detection and Antibacterial Phototherapy. Chem.—Asian J. 2023, 18, e202300178. [Google Scholar] [CrossRef] [PubMed]
  8. Barattucci, A.; Campagna, S.; Papalia, T.; Galletta, M.; Santoro, A.; Puntoriero, F.; Bonaccorsi, P. BODIPY on Board of Sugars: A Short Enlightened Journey up to the Cells. ChemPhotoChem 2020, 4, 647–658. [Google Scholar] [CrossRef]
  9. Mahanta, C.S.; Ravichandiran, V.; Swain, S.P. Recent Developments in the Design of New Water-Soluble Boron Dipyrromethenes and Their Applications: An Updated Review. ACS Appl. Bio Mater. 2023, 6, 2995–3018. [Google Scholar] [CrossRef]
  10. Cheng, H.-B.; Cao, X.; Zhang, S.; Zhang, K.; Cheng, Y.; Wang, J.; Zhao, J.; Zhou, L.; Liang, X.-J.; Yoon, J. BODIPY as a Multifunctional Theranostic Reagent in Biomedicine: Self-Assembly, Properties, and Applications. Adv. Mater. 2023, 35, e2207546. [Google Scholar] [CrossRef]
  11. Zou, Y.; Long, S.; Xiong, T.; Zhao, X.; Sun, W.; Du, J.; Fan, J.; Peng, X. Single-Molecule Förster Resonance Energy Transfer-Based Photosensitizer for Synergistic Photodynamic/Photothermal Therapy. ACS Cent. Sci. 2021, 7, 327–334. [Google Scholar] [CrossRef] [PubMed]
  12. Jiang, Y.; Pu, K. Molecular Probes for Autofluorescence-Free Optical Imaging. Chem. Rev. 2021, 121, 13086–13131. [Google Scholar] [CrossRef] [PubMed]
  13. Aversa, M.C.; Barattucci, A.; Bonaccorsi, P.; Temperini, A. Regio- and Stereocontrolled Synthesis of (Z)-α-(Phenylseleno)Sulfinyl and -Sulfonyl Alkenes via Sulfenic Acids, and a Study of Their Reactivity. Eur. J. Org. Chem. 2011, 2011, 5668–5673. [Google Scholar] [CrossRef]
  14. Deni, E.; Zamarrón, A.; Bonaccorsi, P.; Carmen Carreño, M.; Juarranz, Á.; Puntoriero, F.; Sciortino, M.T.; Ribagorda, M.; Barattucci, A. Glucose-Functionalized Amino-OPEs as Biocompatible Photosensitizers in PDT. Eur. J. Med. Chem. 2016, 111, 58–71. [Google Scholar] [CrossRef] [PubMed]
  15. de Matos, A.M. Recent Advances in the Development and Synthesis of Carbohydrate-Based Molecules with Promising Antibacterial Activity. Eur. J. Org. Chem. 2023, 26, e202200919. [Google Scholar] [CrossRef]
  16. Prasannan, D.; Raghav, D.; Sujatha, S.; Kumar, H.H.; Rathinasamy, K.; Arunkumar, C. Synthesis, Structure, Photophysical, Electrochemical Properties and Antibacterial Activity of Brominated BODIPYs. RSC Adv. 2016, 6, 80808–80824. [Google Scholar] [CrossRef]
  17. Santos, V.F.; Costa, M.S.; Campina, F.F.; Rodrigues, R.R.; Santos, A.L.E.; Pereira, F.M.; Batista, K.L.R.; Silva, R.C.; Pereira, R.O.; Rocha, B.A.M.; et al. The Galactose-Binding Lectin Isolated from Vatairea macrocarpa Seeds Enhances the Effect of Antibiotics Against Staphylococcus aureus-Resistant Strain. Probiotics Antimicrob. Proteins 2020, 12, 82–90. [Google Scholar] [CrossRef] [PubMed]
  18. Liu, S.; Li, H.; Zhang, J.; Tian, X.; Li, X. A Biocompatible Supramolecular Hydrogel with Multivalent Galactose Ligands Inhibiting Pseudomonas aeruginosa Virulence and Growth. RSC Adv. 2020, 10, 33642–33650. [Google Scholar] [CrossRef]
  19. Ho, L.K.; Daniel-Ivad, M.; Jeedigunta, S.P.; Li, J.; Iliadi, K.G.; Boulianne, G.L.; Hurd, T.R.; Smibert, C.A.; Nodwell, J.R. Chemical Entrapment and Killing of Insects by Bacteria. Nat. Commun. 2020, 11, 4608. [Google Scholar] [CrossRef]
  20. Calabrese, G.; Petralia, S.; Franco, D.; Nocito, G.; Fabbi, C.; Forte, L.; Guglielmino, S.; Squarzoni, S.; Traina, F.; Conoci, S. A New Ag-Nanostructured Hydroxyapatite Porous Scaffold: Antibacterial Effect and Cytotoxicity Study. Mater. Sci. Eng. C 2021, 118, 111394. [Google Scholar] [CrossRef]
  21. Franco, D.; Calabrese, G.; Petralia, S.; Neri, G.; Corsaro, C.; Forte, L.; Squarzoni, S.; Guglielmino, S.; Traina, F.; Fazio, E.; et al. Antimicrobial Effect and Cytotoxic Evaluation of Mg-Doped Hydroxyapatite Functionalized with Au-Nano Rods. Molecules 2021, 26, 1099. [Google Scholar] [CrossRef] [PubMed]
  22. Li, W.; Thian, E.S.; Wang, M.; Wang, Z.; Ren, L. Surface Design for Antibacterial Materials: From Fundamentals to Advanced Strategies. Adv. Sci. 2021, 8, e2100368. [Google Scholar] [CrossRef] [PubMed]
  23. Yang, X.; Hou, J.; Tian, Y.; Zhao, J.; Sun, Q.; Zhou, S. Antibacterial Surfaces: Strategies and Applications. Sci. China Technol. Sci. 2022, 65, 1000–1010. [Google Scholar] [CrossRef] [PubMed]
  24. Tekdaş, D.A.; Viswanathan, G.; Topal, S.Z.; Looi, C.Y.; Wong, W.F.; Tan, G.M.Y.; Zorlu, Y.; Gürek, A.G.; Lee, H.B.; Dumoulin, F. Antimicrobial Activity of a Quaternized BODIPY against Staphylococcus Strains. Org. Biomol. Chem. 2016, 14, 2665–2670. [Google Scholar] [CrossRef] [PubMed]
  25. Singh, K.; Kulkarni, S.S. Small Carbohydrate Derivatives as Potent Antibiofilm Agents. J. Med. Chem. 2022, 65, 8525–8549. [Google Scholar] [CrossRef] [PubMed]
  26. Alford, M.A.; Mann, S.; Akhoundsadegh, N.; Hancock, R.E.W. Competition between Pseudomonas aeruginosa and Staphylococcus Aureus Is Dependent on Intercellular Signaling and Regulated by the NtrBC Two-Component System. Sci. Rep. 2022, 12, 9027. [Google Scholar] [CrossRef]
  27. Chinchilla, R.; Nájera, C. The Sonogashira Reaction:  A Booming Methodology in Synthetic Organic Chemistry. Chem. Rev. 2007, 107, 874–922. [Google Scholar] [CrossRef] [PubMed]
  28. Fernández, G.; García, F.; Sánchez, L. Morphological Changes in the Self-Assembly of a Radial Oligo-Phenylene Ethynylene Amphiphilic System. Chem. Commun. 2008, 6567–6569. [Google Scholar] [CrossRef]
  29. Kelly, T.L.; Lam, M.C.W.; Wolf, M.O. Carbohydrate-Labeled Fluorescent Microparticles and Their Binding to Lectins. Bioconjug. Chem. 2006, 17, 575–578. [Google Scholar] [CrossRef]
  30. Pawle, R.H.; Agarwal, A.; Malveira, S.; Smith, Z.C.; Thomas, S.W.I. Bandgap Engineering of Conjugated Materials with Nonconjugated Side Chains. Macromolecules 2014, 47, 2250–2256. [Google Scholar] [CrossRef]
  31. Babudri, F.; Colangiuli, D.; Lorenzo, P.A.D.; Farinola, G.M.; Omar, O.H.; Naso, F. Synthesis of Poly(Aryleneethynylene)s Bearing Glucose Units as Substituents. Chem. Commun. 2003, 130–131. [Google Scholar] [CrossRef]
  32. Spicer, C.D.; Davis, B.G. Rewriting the Bacterial Glycocalyx via Suzuki–Miyaura Cross-Coupling. Chem. Commun. 2013, 49, 2747–2749. [Google Scholar] [CrossRef]
  33. Ziessel, R.; Ulrich, G.; Haefele, A.; Harriman, A. An Artificial Light-Harvesting Array Constructed from Multiple Bodipy Dyes. J. Am. Chem. Soc. 2013, 135, 11330–11344. [Google Scholar] [CrossRef]
  34. Sutter, A.; Elhabiri, M.; Ulrich, G. Fluorescent pH-Responsive Probes Based on Water-Soluble Boron-Dipyrromethene (BODIPY) Derivatives, Featuring Long-Wavelength Emission. Chem.—Eur. J. 2018, 24, 11119–11130. [Google Scholar] [CrossRef] [PubMed]
  35. Yu, Y.-H.; Descalzo, A.B.; Shen, Z.; Röhr, H.; Liu, Q.; Wang, Y.-W.; Spieles, M.; Li, Y.-Z.; Rurack, K.; You, X.-Z. Mono- and Di(Dimethylamino)Styryl-Substituted Borondipyrromethene and Borondiindomethene Dyes with Intense near-Infrared Fluorescence. Chem. Asian J. 2006, 1, 176–187. [Google Scholar] [CrossRef] [PubMed]
  36. Loudet, A.; Burgess, K. BODIPY Dyes and Their Derivatives:  Syntheses and Spectroscopic Properties. Chem. Rev. 2007, 107, 4891–4932. [Google Scholar] [CrossRef]
  37. Rurack, K.; Kollmannsberger, M.; Daub, J. Molecular Switching in the Near Infrared (NIR) with a Functionalized Boron-Dipyrromethene Dye. Angew. Chem. Int. Ed. Engl. 2001, 40, 385–387. [Google Scholar] [CrossRef] [PubMed]
  38. Ansel, H.C.; Norred, W.P.; Roth, I.L. Antimicrobial Activity of Dimethyl Sulfoxide against Escherichia coli, Pseudomonas aeruginosa, and Bacillus megaterium. J. Pharm. Sci. 1969, 58, 836–839. [Google Scholar] [CrossRef] [PubMed]
  39. Kirkwood, Z.I.; Millar, B.C.; Downey, D.G.; Moore, J.E. Antimicrobial Effect of Dimethyl Sulfoxide and N, N-Dimethylformamide on Mycobacterium abscessus: Implications for Antimicrobial Susceptibility Testing. Int. J. Mycobacteriol. 2018, 7, 134. [Google Scholar] [CrossRef]
  40. Vereshchagin, A.N.; Frolov, N.A.; Egorova, K.S.; Seitkalieva, M.M.; Ananikov, V.P. Quaternary Ammonium Compounds (QACs) and Ionic Liquids (ILs) as Biocides: From Simple Antiseptics to Tunable Antimicrobials. Int. J. Mol. Sci. 2021, 22, 6793. [Google Scholar] [CrossRef]
  41. Bretti, C.; Cardiano, P.; Irto, A.; Lando, G.; Milea, D.; Sammartano, S. Interaction of N-Acetyl-l-Cysteine with Na+, Ca2+, Mg2+ and Zn2+. Thermodynamic Aspects, Chemical Speciation and Sequestering Ability in Natural Fluids. J. Mol. Liq. 2020, 319, 114164. [Google Scholar] [CrossRef] [PubMed]
  42. Bonaccorsi, P.; Aversa, M.C.; Barattucci, A.; Papalia, T.; Puntoriero, F.; Campagna, S. Artificial light-harvesting antenna systems grafted on a carbohydrate platform. Chem. Commun. 2012, 48, 10550–10552. [Google Scholar] [CrossRef] [PubMed]
  43. Nakamaru, N. Synthesis, Luminescence Quantum Yields, and Lifetimes of Trischelated Ruthenium(II) Mixed-ligand Complexes Including 3,3′-Dimethyl-2,2′-bipyridyl. Bull. Chem. Soc. Jpn. 1982, 55, 2697–2705. [Google Scholar] [CrossRef]
  44. Olmsted, J., III. Calorimetric determinations of absolute fluorescence quantum yields. J. Phys. Chem. 1979, 83, 2581–2584. [Google Scholar] [CrossRef]
  45. Serra, R.; Grande, R.; Butrico, L.; Rossi, A.; Settimio, U.F.; Caroleo, B.; Amato, B.; Gallelli, L.; de Franciscis, S. Chronic wound infections: The role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev. Anti. Infect. Ther. 2015, 13, 605–613. [Google Scholar] [CrossRef]
  46. Fischer, A.J.; Singh, S.B.; LaMarche, M.M.; Maakestad, L.J.; Kienenberger, Z.E.; Peña, T.A.; Stoltz, D.A.; Limoli, D.H. Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 2021, 203, 328–338. [Google Scholar] [CrossRef]
Molecules 29 02299 g001
Figure 1. Schematic representations of GalTEBB-1 and GalTEBB-2.
Figure 1. Schematic representations of GalTEBB-1 and GalTEBB-2.
Molecules 29 02299 g001
Molecules 29 02299 sch001
Scheme 1. Synthethic route to digalactoside (compound 4).
Scheme 1. Synthethic route to digalactoside (compound 4).
Molecules 29 02299 sch001
Molecules 29 02299 sch002
Scheme 2. Synthetic routes to GalTEBB-1 and GalTEBB-2.
Scheme 2. Synthetic routes to GalTEBB-1 and GalTEBB-2.
Molecules 29 02299 sch002
Molecules 29 02299 g002
Figure 2. Absorption spectra of GalTEBB-1 (green line) and GalTEBB-2 (blue line) in CH3CN solution.
Figure 2. Absorption spectra of GalTEBB-1 (green line) and GalTEBB-2 (blue line) in CH3CN solution.
Molecules 29 02299 g002
Molecules 29 02299 g003
Figure 3. Emission spectra of GalTEBB-1 (green line) and GalTEBB-2 (blue line) in CH3CN solution.
Figure 3. Emission spectra of GalTEBB-1 (green line) and GalTEBB-2 (blue line) in CH3CN solution.
Molecules 29 02299 g003
Molecules 29 02299 sch003
Scheme 3. Simplified Jablonski diagram summarizing the photophysics of GalTEBB-1 (top panel) and GalTEBB-2 (bottom panel).
Scheme 3. Simplified Jablonski diagram summarizing the photophysics of GalTEBB-1 (top panel) and GalTEBB-2 (bottom panel).
Molecules 29 02299 sch003
Molecules 29 02299 g004
Figure 4. Antibacterial activity of DMSO (orange), GalTEBB-1 (green), and GalTEBB-2 (blue) against P. aeruginosa and S. aureus. The percentages of DMSO refer to the concentrations of the organic solvent in the GalTEBB-1 and GalTEBB-2 solutions (see Table S1).
Figure 4. Antibacterial activity of DMSO (orange), GalTEBB-1 (green), and GalTEBB-2 (blue) against P. aeruginosa and S. aureus. The percentages of DMSO refer to the concentrations of the organic solvent in the GalTEBB-1 and GalTEBB-2 solutions (see Table S1).
Molecules 29 02299 g004
Table 1. Absorption and emission data in acetonitrile at 298 K.
Table 1. Absorption and emission data in acetonitrile at 298 K.
AbsorptionEmission
λmax/nm (ε/M−1 cm−1)λmax/nmτ/nsΦ
GalTEBB-1500 (120,300)
700 (95,900)		7902.20.20
GalTEBB-2500 (102,600)
610 (122,300)		6255.60.7
Table 2. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of DMSO alone (%, w/v), GalTEBB-1 (µg/mL), and GalTEBB-2 (µg/mL) for S. aureus and P. aeruginosa at 37 °C.
Table 2. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of DMSO alone (%, w/v), GalTEBB-1 (µg/mL), and GalTEBB-2 (µg/mL) for S. aureus and P. aeruginosa at 37 °C.
CompoundsP. aeruginosaS. aureus
MIC MBC MIC MBC
DMSO alone6.25%12.5% 25%25%
GalTEBB-1125 µg/mL (6.25%)125 µg/mL (6.25%)250 µg/mL (12.5%)250 µg/mL (12.5%)
GalTEBB-2125 µg/mL (6.25%)125 µg/mL (6.25%)250 µg/mL (12.5%)250 µg/mL (12.5%)
In parenthesis, we show the proportional value of DMSO in the galactoconjugate solutions (Table S1).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gangemi, C.M.A.; Monforte, M.; Arrigo, A.; Bonaccorsi, P.M.; Conoci, S.; Iaconis, A.; Puntoriero, F.; Franco, D.; Barattucci, A. Synthesis of Bodipy-Tagged Galactoconjugates and Evaluation of Their Antibacterial Properties. Molecules 2024, 29, 2299. https://doi.org/10.3390/molecules29102299

AMA Style

Gangemi CMA, Monforte M, Arrigo A, Bonaccorsi PM, Conoci S, Iaconis A, Puntoriero F, Franco D, Barattucci A. Synthesis of Bodipy-Tagged Galactoconjugates and Evaluation of Their Antibacterial Properties. Molecules. 2024; 29(10):2299. https://doi.org/10.3390/molecules29102299

Chicago/Turabian Style

Gangemi, Chiara Maria Antonietta, Maura Monforte, Antonino Arrigo, Paola Maria Bonaccorsi, Sabrina Conoci, Antonella Iaconis, Fausto Puntoriero, Domenico Franco, and Anna Barattucci. 2024. "Synthesis of Bodipy-Tagged Galactoconjugates and Evaluation of Their Antibacterial Properties" Molecules 29, no. 10: 2299. https://doi.org/10.3390/molecules29102299

APA Style

Gangemi, C. M. A., Monforte, M., Arrigo, A., Bonaccorsi, P. M., Conoci, S., Iaconis, A., Puntoriero, F., Franco, D., & Barattucci, A. (2024). Synthesis of Bodipy-Tagged Galactoconjugates and Evaluation of Their Antibacterial Properties. Molecules, 29(10), 2299. https://doi.org/10.3390/molecules29102299

Article Metrics

Back to TopTop